Tiziana Life Sciences Ltd Chief Executive Officer Ivor Elrifi acquired 1,050,000 shares through an option exercise on August 15, 2026, according to the supplied summary of an SEC Form 4 report. The company trades under the ticker TLSA.

The SEC item carries a supplied publication timestamp of September 29, 2026, at 21:13:13 UTC. That timestamp identifies when the item was published in the supplied record; it does not independently establish the filing’s submission date. The transaction date reported in the summary is August 15.

What the report says

The disclosed acquisition resulted from exercising options. It should therefore be described as an option exercise, rather than an open-market purchase. The reported amount is a share count—1,050,000—not a dollar value.

The source summary also marks the transaction as having no Rule 10b5-1 plan. That is a reported detail of this transaction, not evidence about whether Elrifi has used such arrangements for other transactions.

The supplied material identifies Elrifi as the reporting insider and Tiziana’s chief executive. It does not provide an exercise price, total exercise cost, post-transaction shareholding or any accompanying disposition of shares. Those details cannot be calculated or established from the share count alone.

How to interpret the disclosure

Analysis: The filing is relevant as a disclosure of an executive’s equity transaction. Its significance is limited by the information available: an option exercise alone does not establish the insider’s investment outlook or explain why the options were exercised on that date.

The summary also does not establish a change in the company’s operating performance, financial outlook or market valuation. No conclusion about those matters follows from the reported acquisition.

What to watch

The full Form 4 would be the next document to review for the submission date, exercise terms, resulting ownership and any related transaction entries. Until those details are verified, the supported account remains the reported option exercise, its share count, transaction date and stated absence of a 10b5-1 plan.